News

AOL

ANPC: AnPac Cancer Differentiation Analysis (CDA) Technology

AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) adopts a novel approach to screening and detecting cancer that we see as establishing a new paradigm in routine checkup screening, as well as being ...
Nasdaq

AnPac Bio Reports Record Q1 for Paid CDA-Based Cancer Testing Volume in 2021, Increasing Approximately 130% Compared to Q1, 2020

SAN JOSE, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the ...
Nasdaq

China’s NMPA Approved Starting of Registration Testing of AnPac Bio Class III Medical Device (For Lung Cancer Auxiliary Diagnosis Utility)

SAN JOSE, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United ...
Benzinga.com

AnPac Bio-Medical Science Releases Financial, Operations Report for Latest Period

AnPac Bio-Medical Science ANPC, a biotechnology company with operations in China and the United States focused on early cancer screening and detection has reported its unaudited financial results and ...